CAT - catalase Gene

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 847

About CAT

Cytogenetic location: 11p13 Genomic coordinates (GRCh38): 11:34,438,934-34,472,060 (from NCBI)

This gene has 6 transcripts (splice variants), 240 orthologues and is associated with 2 phenotypes. Broad expression in liver (RPKM 283.8), fat (RPKM 207.7) and 23 other tissues.

Summary

This gene encodes catalase, a key antioxidant enzyme in the bodies defense against oxidative stress. Catalase is a heme enzyme that is present in the peroxisome of nearly all aerobic cells. Catalase converts the Reactive Oxygen Species hydrogen peroxide to water and oxygen and thereby mitigates the toxic effects of hydrogen peroxide. Oxidative stress is hypothesized to play a role in the development of many chronic or late-onset diseases such as diabetes, asthma, Alzheimer's disease, systemic lupus erythematosus, rheumatoid arthritis, and cancers. Polymorphisms in this gene have been associated with decreases in catalase activity but, to date, acatalasemia is the only disease known to be caused by this gene. [provided by RefSeq, Oct 2009]

CAT Products (1)

mRNA	Protein	Name
NM_001752.4	NP_001743.1	catalase

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables NADP binding	IDA IDA: Inferred from direct assay	10656833	GOA
enables antioxidant activity	IDA IDA: Inferred from direct assay	10514471	GOA
enables catalase activity	IDA IDA: Inferred from direct assay	7882369	GOA
enables enzyme binding	IPI IPI: Inferred from physical interaction	16781659	GOA
enables heme binding	IDA IDA: Inferred from direct assay	10656833	GOA
enables identical protein binding	IPI IPI: Inferred from physical interaction	21976670	GOA
enables protein homodimerization activity	IDA IDA: Inferred from direct assay	10656833	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in UV protection	IMP IMP: Inferred from mutant phenotype	16644728	GOA
involved in cellular detoxification of hydrogen peroxide	IDA IDA: Inferred from direct assay	18379038	GOA
involved in hydrogen peroxide catabolic process	IDA IDA: Inferred from direct assay	18379038	GOA
involved in negative regulation of apoptotic process	IMP IMP: Inferred from mutant phenotype	16644728	GOA
involved in response to reactive oxygen species	IMP IMP: Inferred from mutant phenotype	16644728	GOA

Cellular Component GO Annotation	Evidence	References	Source
part of catalase complex	IPI IPI: Inferred from physical interaction	10656833	GOA
is active in peroxisome	IDA IDA: Inferred from direct assay	8769411	GOA
located in peroxisome	IDA IDA: Inferred from direct assay	2895531	GOA
part of protein-containing complex	IPI IPI: Inferred from physical interaction	21976670	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CAT Protein Structure

Catalase

Catalase-rel

0
100
200
300
400
500
527 a.a.

Protein Preferred Names	Protein Names
catalase	epididymis secretory sperm binding protein

CAT Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	References
Intra	CAT	P04040	TYSND1	Homo sapiens	Q2T9J0	Pull Down	29568061
Intra	CAT	P04040	TYSND1	Homo sapiens	Q2T9J0	BioID	29568061
Intra	CAT	P04040	PTPN11	Homo sapiens	Q06124	Anti Bait CoIP	15556604
Intra	CAT	P04040	CAT	Homo sapiens	P04040	BioID	29568061
Intra	CAT	P04040	CAT	Homo sapiens	P04040	Pull Down	29568061
Intra	CAT	P04040	TYSND1	Homo sapiens	Q2T9J0	Confocal	22002062
Intra	CAT	P04040	PTPN11	Homo sapiens	Q06124	Pull Down	15556604
Intra	CAT	P04040	SMARCA4	Homo sapiens	P51532	BioID	29568061
Intra	CAT	P04040	CAT	Homo sapiens	P04040	Y2H	21988832
Intra	CAT	P04040	ACOX1	Homo sapiens	Q15067	BioID	29568061
Intra	CAT	P04040	ACOX1	Homo sapiens	Q15067	Pull Down	29568061
Intra	CAT	P04040	SMARCA4	Homo sapiens	P51532	Anti Tag CoIP	26496610
Intra	CAT	P04040	APP	Homo sapiens	P05067	ELISA	10567208

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant CAT Proteins

Cat. No.	Product Name	Accession	Purity
HY-P7744	Catalase Protein, Human	P04040 (A2-L527)	≥ 90%, as determined by reducing SDS-PAGE.
HY-P7744A	Catalase Protein, Human (His)	P04040 (A2-L527)	≥ 95%, as determined by reducing SDS-PAGE.

CAT Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P80051	Catalase Antibody (YA552)	WB, IHC-P	Human, Mouse, Rat
HY-P80052	Catalase Antibody (YA811)	WB, ICC/IF, IHC-P, FC	Human, Mouse, Rat
HY-P86618	Catalase Antibody (YA6310)	WB, IHC-P, ICC/IF, ELISA	Human, Mouse, Rat

Related Diseases

Diseases	Alias
Acatalasemia	Acatalasia Catalase Deficiency Deficiency Of Catalase ACATLAS Takahara'S Disease Takahara Disease
Pityriasis Versicolor	Tinea Versicolor Infection By Pityrosporum Furfur
Acne	Acne Vulgaris Acne Varioliformis Frontalis Acne
Peroxisome Biogenesis Disorder 1b	Peroxisome Biogenesis Disorder Infantile Refsum Disease Infantile Phytanic Acid Storage Disease PBD1B Refsum Disease, Infantile Adrenoleukodystrophy, Autosomal Neonatal Ird Mild Pbd-Zsd Mild Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder Pbd-Zsd Peroxisome Biogenesis Disorder Spectrum Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder Autosomal Neonatal Adrenoleukodystrophy Refsum Disease Infantile Peroxisome Biogenesis Disorders Peroxisome Biogenesis Disorder, Type 1b
Neonatal Adrenoleukodystrophy	Nald Adrenoleukodystrophy Autosomal Neonatal Form Intermediate Pbd-Zsd Intermediate Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder Adrenoleukodystrophy, Autosomal, Neonatal Form Adrenoleukodystrophy Neonatal Adrenoleukodystrophy, Neonatal
Diabetic Angiopathy	Diabetic Angiopathies Diabetic Peripheral Angiopathy Diabetic Vascular Disorder
Chronic Granulomatous Disease	Cgd Granulomatous Disease, Chronic Autosomal Recessive Chronic Granulomatous Disease X-Linked Chronic Granulomatous Disease Bridges-Good Syndrome Congenital Dysphagocytosis Quie Syndrome Chronic Septic Granulomatosis Chronic Granulomatous Disorder Granulomatous Disease Chronic Granulomatous Disease, Chronic, X-Linked
Zellweger Syndrome	Cerebrohepatorenal Syndrome Zellweger Leukodystrophy Zs Congenital Iron Overload Chr Zws Severe Pbd-Zsd Severe Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder
Erysipelas
Hemosiderosis	Haemosiderosis Iron Overload
Myeloperoxidase Deficiency	Mpo Deficiency MPOD
Asbestosis	Idiopathic Interstitial Pneumonitis - From Asbestos Exposure Pulmonary Fibrosis - From Asbestos Exposure
Peroxisomal Disease	Peroxisomal Disorder Peroxisomal Disorders Peroxisomal Defects
Cryptosporidiosis	Cryptosporidial Gastroenteritis Intestinal Cryptosporidiosis Infection By Cryptosporidium Gastroenteritis Due To Cryptosporidium Cryptosporidial Infection
Pneumoconiosis	Pneumoconioses Silicosis Nos Complicated Silicosis Fibrosis Of Lung With Silicosis Nodular Silicosis Pneumoconiosis Due To Silica Silicotic Fibrosis Of Lung Simple Silicosis Silicatosis Silicotic Lung Fibrosis Pneumoconiosis Due To Talc Pulmonary Talcosis Talc Lung Disease Talc Pneumoconiosis Talc Workers' Pneumoconiosis Talcosis Fibrosis Of Lung Due To Talc Asbestos Pneumoconiosis Amianthosis Asbestosis Lung Fibrosis With Asbestosis Pulmonary Asbestosis
Maple Syrup Urine Disease	MSUD Bckd Deficiency Branched-Chain Ketoaciduria Branched-Chain Alpha-Keto Acid Dehydrogenase Deficiency Keto Acid Decarboxylase Deficiency Maple Syrup Urine Disease, Type Ii Branched Chain Ketoaciduria Classic Maple Syrup Urine Disease Intermittent Maple Syrup Urine Disease Maple Syrup Urine Disease, Type Ia Ketoacidaemia Bckdh Deficiency Branched-Chain 2-Ketoacid Dehydrogenase Deficiency Thiamine-Responsive Maple Syrup Urine Disease Intermediate Maple Syrup Urine Disease Maple Syrup Urine Disease Type 1a Maple Syrup Urine Disease Type 1b Maple Syrup Urine Disease Type 2 Maple Syrup Urine Disease, Type Ib Dihydrolipoamide Dehydrogenase Deficiency Branched-Chain Ketoacid Dehydrogenase Deficiency Maple Syrup Disease Ketoacidemia Classic Bckd Deficiency Classic Msud Classic Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency Classic Branched-Chain Ketoaciduria Thiamine-Responsive Bckd Deficiency Thiamine-Responsive Msud Thiamine-Responsive Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency Intermittent Bckd Deficiency Intermittent Msud Intermittent Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency Maple Syrup Urine Disease 1a MSUD1A Maple Syrup Urine Disease Type Ia Msud Type Ia Maple Syrup Urine Disease 1b MSUD1B Maple Syrup Urine Disease Type Ib Msud Type Ib Maple Syrup Urine Disease 2 MSUD2 Maple Syrup Urine Disease Type Ii Msud Type Ii Nadh Cytochrome B5 Reductase Deficiency Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency Ketonemia Maple Syrup Urine Disease, Type 1b Ketoacid Decarboxylase Deficiency Oxoacid Decarboxylase Deficiency Branched Chain Ketoacid Dehydrogenase Deficiency Msud - [Maple-Syrup-Urine Disease] Ketoaminoacidaemia Bckd - [Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency] Maple-Syrup-Urine Disorder Maple-Syrup-Urine Syndrome
Bacteriuria
Asthma	Chronic Obstructive Asthma Asthma, Diminished Response To Antileukotriene Treatment In Bronchial Hyperreactivity Asthma, Susceptibility To Asthma, Bronchial Asthma, Protection Against Asthma, Nocturnal, Susceptibility To Nocturnal Asthma Asthma-Related Traits Asthma-Related Traits, Susceptibility To Asthma, Nocturnal Chronic Obstructive Asthma With Acute Exacerbation Chronic Obstructive Asthma With Status Asthmaticus Exercise Induced Asthma Exercise-Induced Asthma Bronchial Asthma Asthma, Exercise-Induced Idiosyncratic Asthma Unspecified Asthma With Acute Exacerbation Asthma, Unspecified, With Stated Status Asthmaticus Status Asthmaticus Nos Acute Severe Asthma Acute Severe Bronchial Asthma Status Asthma Status Post Asthmaticus
Rhizomelic Chondrodysplasia Punctata	Chondrodysplasia Punctata, Rhizomelic Rcdp Chondrodysplasia Punctata, Rhizomelic Form Rcp Chondrodysplasia Punctata Rhizomelic
Iron Deficiency Anemia	Iron-Deficiency Anemia Fe Deficiency Anaemia Ida - [Iron Deficiency Anemia] Fe - [Iron] Deficiency Anemia Nos
Syphilis	Chancre Syphilitic Chancre
Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1	Vitiligo VAMAS1 Slev1 Vtlg Systemic Lupus Erythematosus, Vitiligo-Related Vitiligo-Associated Multiple Autoimmune Disease 1 Systemic Lupus Erythematosus Vitiligo-Related
Atrophic Gastritis	Gastritis, Atrophic Gastric Atrophy Gastritis Atrophic
Refsum Disease, Classic	Refsum Disease Heredopathia Atactica Polyneuritiformis Phytanic Acid Oxidase Deficiency Hmsn Iv Refsum Disease, Adult, 1 Refsum'S Disease Phytanic Acid Storage Disease Hereditary Motor And Sensory Neuropathy Iv Hmsn4 Hmsn Type Iv Hmsn 4 Adult Refsum Disease Classic Refsum Disease Hereditary Motor And Sensory Neuropathy Type Iv Refsum Syndrome Hsmn Iv Disorder Of Cornification 11 Doc 11 Hereditary Sensory And Motor Neuropathy Type 4 Hypertrophic Neuropathy Of Refsum Ard Crd Hereditary Motor And Sensory Neuropathy Type 4 Phytanic-Coa Hydroxylase Deficiency RD
Rheumatoid Arthritis	RA Arthritis, Rheumatoid Rheumatoid Arthritis, Susceptibility To Arthritis Or Polyarthritis, Rheumatic Atrophic Arthritis Rheumatism Arthritis Rheumatoid Polyarthritis
Systemic Lupus Erythematosus	Lupus Nephritis SLE Disseminated Lupus Erythematosus Systemic Lupus Erythematosus, Susceptibility To Lupus Erythematosus, Systemic Lupus Nephritis, Susceptibility To Libman-Sacks Disease Systemic Lupus Erythematosus Susceptibility To Sle - Lupus Erythematosus, Systemic Le Syndrome Lupus Lupus Erythematosus Systemic Lupus Erythematosus, Systemic, Susceptibility To Lupus Vulgaris Lupus Erythematosus, Discoid Lupus Erythematosus Systemic Lupus Erythematosus Nos Sle - [Systemic Lupus Erythematosus]
Diabetes Mellitus	Diabetes
Male Infertility	Infertility, Male Infertility Male Male Sterility Absolute Infertility
Glycogen Storage Disease	Glycogenosis Glycogenoses Gsd Storage Disease, Glycogen Gsd - [Glycogen Storage Disease] Glycogen Thesaurismosis Diffuse Glycogenosis Generalised Glycogen Storage Disease Generalised Glycogenosis Generalised Glycogen Storage Disease Of Infants Glycogen Synthase Deficiency
Melanoma	Malignant Melanoma Cutaneous Melanoma Naevocarcinoma Malignant Melanomas
Tetralogy Of Fallot	TOF Fallot Tetralogy Ventricular Septal Defect With Pulmonary Stenosis Or Atresia, Dextraposition Of Aorta, And Hypertrophy Of Right Ventricle Tetrad Of Fallot Fallot Tetrad Fallot Disease Fallot Complex Subpulmonic Stenosis, Ventricular Septal Defect, Overriding Aorta, And Right Ventricular Hypertrophy Interventricular Septal Defect With Dextroposition Of Aorta, Pulmonary Stenosis And Hypertrophy Of Right Ventricle Interventricular Septal Defect, In Tetralogy Of Fallot Ventricular Septal Defect With Obstructed Right Ventricular Outflow Tof - [Tetralogy Of Fallot] Pulmonary Atresia With Ventricular Septal Defect [Fallot Type] Pulmonary Atresia, Ventricular Septal Defect And Mapcas Pulmonary Atresia With Ventricular Septal Defect And Systemic-To-Pulmonary Collateral Arteries [Fallot Type]
Constipation
Skin Disease	Skin Diseases Genodermatosis Abnormality Of The Skin Skin Diseases, Genetic Skin And Subcutaneous Tissue Disease Dermatologic Disorders
Bacteremia 2	Bacteremia Bacteremia, Susceptibility To, 2 BACTS2 Bacteremia, Susceptibility To Bacteremia, Susceptibility To, Type 2
Type 2 Diabetes Mellitus	Insulin Resistance NIDDM Type 2 Diabetes Diabetes Mellitus, Non-Insulin-Dependent T2D Noninsulin-Dependent Diabetes Mellitus Diabetes Mellitus, Type Ii Maturity-Onset Diabetes Insulin Resistance, Severe, Digenic Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Noninsulin-Dependent, Association With Diabetes Mellitus, Noninsulin-Dependent, Late Onset Hypertension, Insulin Resistance-Related, Susceptibility To Insulin Resistance, Susceptibility To Non-Insulin-Dependent Diabetes Mellitus Type Ii Diabetes Mellitus Adult-Onset Diabetes Mellitus Maturity-Onset Diabetes Mellitus Diabetes Mellitus Type 2 Type Ii Diabetes Type 2 Diabetes Mellitus, Susceptibility To Diabetes, Type 2 Diabetes Mellitus, Noninsulin-Dependent, Susceptibility To Diabetes Mellitus, Non-Insulin-Dependent, Susceptibility To Diabetes Mellitus, Type 2, Susceptibility To Diabetes Mellitus, Noninsulin-Dependent, 2 Diabetes Mellitus, Type Ii, Susceptibility To Hypertension, Insulin Resistance-Related Adult-Onset Diabetes Aodm Diabetes Mellitus, Adult-Onset Diabetes Mellitus Type Ii Diabetes Mellitus Type 2, Susceptibility To Diabetes, Type Ii, Susceptibility To Diabetes Type 2 Diabetes Mellitus Adult Onset Diabetes Maturity Onset Diabetes Nonketotic Diabetes Non-Insulin Dependent Diabetes Mellitus T2dm - [Type 2 Diabetes Mellitus] Niddm - [Non Insulin Dependent Diabetes Mellitus] Dm2 Dm Type Ii Diabetic Type 2 Insulin Requiring Type 2 Diabetes Noninsulin Dependent Diabetes Non-Insulin-Dependent Diabetes Mellitus Without Complications Diabetes Due To Insulin Secretory Defect Diabetes Mellitus Due To Insulin Secretory Defect Non-Insulin-Dependent Diabetes Of The Young Senile Diabetes Nonketotic Hyperglycaemia Stable Diabetes
Motor Neuron Disease	Anterior Horn Cell Disease Motor Neuron Diseases Mnd - [Motor Neurone Disease] Lou Gehrig Disease Creeping Palsy Creeping Paralysis Bulbar Motor Neuron Disease Bulbar Syndrome Anterior Horn Cell Disorder Hereditary Motor Neuron Disease
Cerebral Palsy	Infantile Cerebral Palsy Mixed Cerebral Palsy Palsy Cerebral Palsy, Cerebral Cerebral Palsy, Mixed
Acute Promyelocytic Leukemia	Leukemia, Acute Promyelocytic Acute Myeloblastic Leukemia Type 3 Aml M3 APL Leukemia, Acute Promyelocytic, Somatic Aml With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Apml Acute Myeloblastic Leukemia 3 Acute Myeloid Leukemia With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Acute Myeloblastic Leukaemia Type 3 Acute Myeloid Leukaemia M3 Acute Myeloid Leukemia M3 Acute Promyelocytic Leukaemia M3 Anll Myeloid Leukemia, Acute, M3 Leukemia Promyelocytic Acute Leukemia, Promyelocytic, Acute Leukemia, Acute, Promyelocytic

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (31)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0988	Deferoxamine mesylate		99.86%	Unkown
HY-B1625	Deferoxamine		99.76%	Yes
HY-Y0682	Ethylenediaminetetraacetic acid		98.29%	Unkown
HY-B0193A	Prazosin hydrochloride		99.89%	Unkown
HY-75161	(-)-Menthol	Activator	99.79%	Unkown
HY-P0163	Gramicidin	Inhibitor	99.5%	Unkown
HY-B0377	Famotidine		99.85%	Yes
HY-B1836	Meldonium	Activator	99.89%	Unkown
HY-B1221	Flufenamic acid		99.98%	Unkown
HY-113218	Acetyl-L-carnitine	Inhibitor	99.86%	Unkown
HY-N7075	Inulin		/	Unkown
HY-109556	Insulin Detemir	Activator	95.0%	Unkown
HY-B0565	Ronidazole	Inhibitor	99.81%	Unkown
HY-B1213	Trimipramine maleate		99.88%	Unkown
HY-B1203A	Fludrocortisone acetate		99.59%	Unkown
HY-A0066A	Tolazoline hydrochloride	Antagonist	99.93%	Unkown
HY-B1833	Afloqualone	Agonist	99.91%	Unkown
HY-B1836A	Meldonium dihydrate	Activator	99.0%	Unkown
HY-B1330	Proglumide	Antagonist	99.84%	Yes
HY-119572	Sodium zirconium cyclosilicate		95.0%	Unkown
HY-B0416	Gallamine Triethiodide		99.56%	Unkown
HY-W011602	Triethyl citrate		98.93%	Unkown
HY-103354	Proglumide sodium	Antagonist	99.58%	Yes
HY-W014332	1,3-Diphenylguanidine		99.76%	Unkown
HY-B1009	Ethylenediaminetetraacetic acid trisodium salt		98.0%	Unkown
HY-W011602R	Triethyl citrate (Standard)		99.57%	Unkown
HY-B0932R	Levocarnitine propionate hydrochloride (Standard)		/	Unkown
HY-103354A	Proglumide hemicalcium	Antagonist	/	Unkown
HY-B0193AR	Prazosin hydrochloride (Standard)		/	Unkown
HY-B1213A	Trimipramine		/	Unkown
HY-B0416R	Gallamine Triethiodide (Standard)	Inhibitor	/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99053	Tralokinumab	Inhibitor	99.12%	Unkown

Clinical Phase

Bioactive Molecules (22)

Cat. No.	Product Name	Effect	Purity	Phase
HY-N6687	Calcimycin		99.12%	Phase 4
HY-B0762	Acetyl-L-carnitine hydrochloride	Inhibitor	99.95%	Phase 4
HY-W127774	EDTA hydrate sodium		97.0%	Phase 4
HY-117817	Ranelic acid		/	Phase 4
HY-103586	GS-441524	Inhibitor	99.92%	Phase 3
HY-P2141	TRV-120027	Agonist	98.21%	Phase 3
HY-142118	Trabedersen	Inhibitor	91.24%	Phase 3
HY-17630	Edasalonexent	Inhibitor	96.05%	Phase 3
HY-114671	Taprostene	Agonist	98.1%	Phase 3
HY-145728	Alicaforsen	Inhibitor	/	Phase 3
HY-118874	Oblimersen		/	Phase 3
HY-103586R	GS-441524 (Standard)	Inhibitor	/	Phase 3
HY-100516	Cimicoxib	Inhibitor	98.02%	Phase 2
HY-107129	MK-3577	Antagonist	/	Phase 2
HY-A0157B	Dimethothiazine hydrochloride	Antagonist	/	Phase 2
HY-P10515	AcrAP2	Inhibitor	/	Phase 2
HY-15533	LY 3000328	Inhibitor	99.50%	Phase 1
HY-100973A	Adenosine 5′-diphosphoribose sodium		99.47%	Phase 1
HY-19960	BCTC		99.66%	Phase 1
HY-103586A	GS-441524 hydrochloride	Inhibitor	99.62%	Phase 1
HY-180141	AF03	Activator	/	Phase 1
HY-W160358	2,5-Dimethylcyclohexanol	Inhibitor	99.88%	Phase 1

Inhibitory Antibodies (3)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99305	Metelimumab	Inhibitor	98.98%	Phase 2
HY-P99474	Bertilimumab	Inhibitor	97.01%	Phase 2
HY-P99627	Frunevetmab		95.00%	Phase 1

Pre-clinical Phase

Bioactive Molecules (372)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-13434	Ionomycin		99.27%	Unkown
HY-P1410	GsMTx4	Inhibitor	99.89%	Unkown
HY-101840	EIPA		99.73%	Unkown
HY-13434A	Ionomycin calcium		98.32%	Unkown
HY-146245	ODN 1826		99.69%	Unkown
HY-152182	ML-SA5	Agonist	99.69%	Unkown
HY-P1410A	GsMTx4 TFA	Inhibitor	99.85%	Unkown
HY-101840A	EIPA hydrochloride		98.01%	Unkown
HY-112540B	Acetoacetic acid sodium		98.0%	Unkown
HY-129555	Surfactin	Inhibitor	98.96%	Unkown
HY-100973	Adenosine 5′-diphosphoribose		98.21%	Unkown
HY-P1471	Adrenomedullin (AM) (22-52), human	Antagonist	99.61%	Unkown
HY-B1793	Tetraethylammonium chloride	Inhibitor	98.0%	Unkown
HY-W011527	Xanthosine	Activator	99.99%	Unkown
HY-Y1881B	Copper sulfate pentahydrate, for cell culture, 98%		99.99%	Unkown
HY-112540A	Acetoacetic acid lithium		98.0%	Unkown
HY-125623	MitoPerOx		97.41%	Unkown
HY-113469	Cyclic GMP		99.77%	Unkown
HY-126752	Ophthalmic acid	Activator	99.91%	Unkown
HY-Y0682A	Ethylenediaminetetraacetic acid disodium dihydrate		99.9%	Unkown
HY-113486	Lathosterol		99.96%	Unkown
HY-14710	AZ3146	Inhibitor	99.42%	Unkown
HY-Y1881A	Copper sulfate pentahydrate, 99.9%		99.90%	Unkown
HY-D0193	Ponceau 4R		99.84%	Unkown
HY-150726	ODN 1668		99.03%	Unkown
HY-128483	Fusaric acid		99.94%	Unkown
HY-E70004	Microbial neutral proteinase		/	Unkown
HY-112540	Acetoacetic acid		95.0%	Unkown
HY-120601	Alizarin Red S sodium		95.0%	Unkown
HY-100231	Cathepsin inhibitor 1	Inhibitor	99.28%	Unkown
HY-N7700A	Guluronic acid sodium	Inhibitor	98.0%	Unkown
HY-Y0988	Copper(I) chloride		99.45%	Unkown
HY-P5601A	Thanatin TFA	Inhibitor	99.68%	Unkown
HY-107740	Pseudoisocyanine iodide	Inhibitor	99.97%	Unkown
HY-32350	Ercalcitriol	Activator	99.71%	Unkown
HY-122605	TRPM4-IN-1	Inhibitor	99.17%	Unkown
HY-129096	IDT307		99.74%	Unkown
HY-W021358	N,N,N′,N′-Tetramethyl-p-phenylenediamine		99.98%	Unkown
HY-148129	Apecotrep	Inhibitor	99.17%	Unkown
HY-W013579	(S)-(+)-Carvone		99.26%	Unkown
HY-135869	Mito-apocynin (C11)	Inhibitor	99.84%	Unkown
HY-113469A	Cyclic GMP sodium		99.89%	Unkown
HY-101327A	Xamoterol hemifumarate	Agonist	≥99.0%	Unkown
HY-19408	Pyr10	Inhibitor	99.95%	Unkown
HY-110374	NVS-CECR2-1		99.40%	Unkown
HY-B0762S1	Acetyl-L-carnitine-d3-1 hydrochloride	Inhibitor	99.12%	Unkown
HY-W110883	Xylenol orange tetrasodium salt, IND		IND	Unkown
HY-N1378	(E)-Cardamonin		99.84%	Unkown
HY-B0762S	Acetyl-L-carnitine-d3 hydrochloride	Inhibitor	99.79%	Unkown
HY-117685	Cefovecin sodium	Inhibitor	99.79%	Unkown
HY-P2324	Gramicidin A	Inhibitor	≥98.0%	Unkown
HY-W004606	9,9-Dimethyl-9,10-dihydroacridine		99.52%	Unkown
HY-P5601	Thanatin	Inhibitor	99.47%	Unkown
HY-144256	CHD1Li 6.11		99.54%	Unkown
HY-131897	1-Stearoyl-2-arachidonoyl-sn-glycerol	Activator	99.0%	Unkown
HY-146584	Cathepsin C-IN-5	Inhibitor	95.70%	Unkown
HY-W018574	Tetraoctylammonium bromide		98.0%	Unkown
HY-132280	Tirilazad	Inhibitor	98.11%	Unkown
HY-B1827	D-Galacturonic acid hydrate		99.92%	Unkown
HY-W013762	Tributyl citrate		98.33%	Unkown
HY-120601A	Alizarin Red S		95.0%	Unkown
HY-125870	Gellan gum, for cell culture		97.0%	Unkown
HY-159821	Ulacamten	Inhibitor	99.22%	Unkown
HY-N0631	Cornuside	Inhibitor	99.99%	Unkown
HY-P2887	Acetate kinase (ACK)		/	Unkown
HY-W014106	Tetraethylammonium tetrafluoroborate		≥98.0%	Unkown
HY-160610A	Carbamoyl phosphate dilithium salt		/	Unkown
HY-W020249	Sodium ionophore X		98.0%	Unkown
HY-B0927	Hydrastine	Inhibitor	99.57%	Unkown
HY-108460	A-784168	Inhibitor	99.79%	Unkown
HY-112776A	BN82002 hydrochloride	Inhibitor	99.36%	Unkown
HY-139192	Brophenexin		98.74%	Unkown
HY-Y0682S	Ethylenediaminetetraacetic acid-d12		99.98%	Unkown
HY-133825	Cyazofamid	Inhibitor	98.15%	Unkown
HY-121065	BN-82685	Inhibitor	99.05%	Unkown
HY-DY1073	MitoPerOx (solution)		/	Unkown
HY-N2003	D-Tetrahydropalmatine	Antagonist	99.84%	Unkown
HY-N2368	Arecaidine		99.63%	Unkown
HY-B0932S	Levocarnitine propionate-d3 hydrochloride		98.89%	Unkown
HY-B1549	Lauryl benzalkonium chloride		≥97.0%	Unkown
HY-B1636	Dithiazanine iodide	Inhibitor	99.46%	Unkown
HY-D0202	Arsenazo III		95.0%	Unkown
HY-P1077A	CALP1 TFA		98.15%	Unkown
HY-Y0682B	Ethylenediaminetetraacetic acid tetrasodium	Inhibitor	98.0%	Unkown
HY-107835	Flumethrin		99.29%	Unkown
HY-B1827A	D-Galacturonic acid		99.92%	Unkown
HY-E70373	λ Protein phosphatase		/	Unkown
HY-N6790	Nonactin		99.0%	Unkown
HY-W094517	Sodium phosphate dibasic heptahydrate		98.74%	Unkown
HY-W339331	Flubendiamide	Activator	99.42%	Unkown
HY-P2141A	TRV-120027 TFA	Agonist	99.62%	Unkown
HY-P2602	α-Casozepine		99.74%	Unkown
HY-W111692	Sodium polyphosphate, crystal,+200 mesh, 96%		/	Unkown
HY-111527	PPZ2		99.92%	Unkown
HY-171152A	NSC 357754 dihydrochloride	Inhibitor	98.01%	Unkown
HY-B1827R	D-Galacturonic acid hydrate (Standard)		99.92%	Unkown
HY-N3029	Noreugenin	Inhibitor	99.42%	Unkown
HY-W006212	1,4,7-Triazonane		99.62%	Unkown
HY-W011087	Benzyldimethyltetradecylammonium chloride		99.70%	Unkown
HY-W014408	Tetraethylammonium bromide		98.0%	Unkown
HY-76632	4-Hydroxyisophthalic acid	Activator	99.51%	Unkown
HY-W103463	1-Phenyl-2-pyrrolidinone	Inhibitor	99.86%	Unkown
HY-100634	4-Hydroxypropranolol hydrochloride	Antagonist	99.73%	Unkown
HY-107535	AS1269574		99.84%	Unkown
HY-109077	Tigolaner		99.37%	Unkown
HY-145150	TRPC5-IN-1	Inhibitor	98.97%	Unkown
HY-P1770	Adrenomedullin (16-31), human		99.96%	Unkown
HY-158222	Alginate Methacryloyl (MW 50000)		/	Unkown
HY-46846	Styrene-divinylbenzene sulfonated copolymer		98%	Unkown
HY-W013264A	Tetrabutylammonium chloride monohydrate		99.96%	Unkown
HY-W587415	cis/trans-Nepetalactol		95.0%	Unkown
HY-W754777	IPPD-Q	Activator	97.38%	Unkown
HY-10656	SB-657510	Antagonist	99.84%	Unkown
HY-116161A	17-Phenyl trinor PGF2α isopropyl ester		99.76%	Unkown
HY-117865	GNE-886	Inhibitor	99.81%	Unkown
HY-128383	1-Methylpyrrolidine		99.02%	Unkown
HY-139192A	Brophenexin free base		99.24%	Unkown
HY-158222A	Alginate Methacryloyl (MW 300000)		/	Unkown
HY-N4309A	Lotusine hydroxide	Inhibitor	99.56%	Unkown
HY-N5073	Vitexin-4''-O-glucoside	Inhibitor	99.81%	Unkown
HY-N7653	Azaleatin		98.86%	Unkown
HY-P10118A	Cathepsin L-IN-3 TFA	Inhibitor	98.18%	Unkown
HY-W011972	Bromocholine bromide		98.0%	Unkown
HY-W015815	6-Methylnicotinamide		99.98%	Unkown
HY-W016638	1-Butyl-1-methylpyrrolidinium chloride		98.0%	Unkown
HY-W753904	Pradofloxacin	Inhibitor	98.02%	Unkown
HY-B2035	Pretilachlor		99.25%	Unkown
HY-W127739	Zineb		/	Unkown
HY-12761	A-836339	Agonist	99.84%	Unkown
HY-113469B	Cyclic GMP TBAOH		/	Unkown
HY-123449	MK-761 free base	Inhibitor	99.56%	Unkown
HY-131897S	1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol	Activator	99.13%	Unkown
HY-135868	Mito-apocynin (C2)	Inhibitor	98.41%	Unkown
HY-137155	Dapsone hydroxylamine	Inhibitor	99.3%	Unkown
HY-158405	PAV-104		99.83%	Unkown
HY-171657	4'-Acetoxy resveratrol		99.90%	Unkown
HY-B0762R	Acetyl-L-carnitine hydrochloride (Standard)	Inhibitor	99.95%	Unkown
HY-B1221S1	Flufenamic acid-13C6		/	Unkown
HY-P1077	CALP1		98.44%	Unkown
HY-RS03139	CRAT Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W011052	Tetrapentylammonium bromide		98.0%	Unkown
HY-W012450	Trimethylphenylammonium bromide		98.0%	Unkown
HY-W127701	[Bmpip][NTf2]		97.0%	Unkown
HY-W654000	Cyclic GMP-13C,15N2		98.81%	Unkown
HY-W781133	cDPCP		99.9%	Unkown
HY-Y0682S1	Ethylenediaminetetraacetic acid-d16		99.1%	Unkown
HY-14830	SAR 97276	Inhibitor	98.05%	Unkown
HY-171152	NSC 357754	Inhibitor	/	Unkown
HY-N19254	Shepherdine	Inhibitor	98.40%	Unkown
HY-N4309	Lotusine	Inhibitor	99.91%	Unkown
HY-101327	Xamoterol	Agonist	/	Unkown
HY-107345	Droxicam	Inhibitor	99.59%	Unkown
HY-108446	GSK 1562590 hydrochloride	Antagonist	99.0%	Unkown
HY-111297	BMVC4		/	Unkown
HY-112776	BN82002	Inhibitor	/	Unkown
HY-113486R	Lathosterol (Standard)		96.91%	Unkown
HY-149203A	MQA-P TFA		97.36%	Unkown
HY-153613	Ac-PLVE-FMK	Inhibitor	98.0%	Unkown
HY-155254	Sodium ionophore VI		98.0%	Unkown
HY-161772	(S)-Gebr32a	Inhibitor	98.97%	Unkown
HY-172342	MitoA bromide		99.4%	Unkown
HY-B0932S2	Levocarnitine propionate-d9 hydrochloride		99%	Unkown
HY-E70012	Penicillinase		/	Unkown
HY-E70191	β-1,4-Galactosyltransferase 2		/	Unkown
HY-N10144	Shinpterocarpin	Inhibitor	/	Unkown
HY-N7700	Guluronic acid	Inhibitor	98.90%	Unkown
HY-P5898	Z-Val-Val-Nle-diazomethylketone	Inhibitor	/	Unkown
HY-W014536	N,N,N-Trimethyloctan-1-aminium chloride		99.0%	Unkown
HY-W073128	Perfluorotetradecanoic acid		98.0%	Unkown
HY-W105699	EDTA tetrasodium tetrahydrate		97.0%	Unkown
HY-W110904	Methylthymol blue tetrasodium		/	Unkown
HY-W767865	Cyclic GMP sodium-13C5		99.03%	Unkown
HY-116778	Prostaglandin G2	Inducer	99.9%	Unkown
HY-147774	Cathepsin K inhibitor 6	Inhibitor	98.18%	Unkown
HY-N11424	Bilirubin diglucuronide	Substrate	/	Unkown
HY-N8707	Homobutein	Inhibitor	98.35%	Unkown
HY-RS29475	CEPT1 Human/Cat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W105700	Ethylenediaminetetraacetic acid sodium hydrate		98.0%	Unkown
HY-W739372	Poly(sodium 4-styrenesulfonate)		/	Unkown
HY-103586S2	GS-441524-d	Inhibitor	/	Unkown
HY-100057	BMY 28674	Antagonist	/	Unkown
HY-101745B	Rocastine fumarate	Inhibitor	/	Unkown
HY-10290	MK-0674	Inhibitor	/	Unkown
HY-103216A	RWJ52353 hydrochloride	Agonist	/	Unkown
HY-105628	Prodilidine		/	Unkown
HY-106074	Mexiprostil		/	Unkown
HY-107644	AQ-RA 741	Antagonist	/	Unkown
HY-107756	LOE 908 hydrochloride	Inhibitor	/	Unkown
HY-107835R	Flumethrin (Standard)		/	Unkown
HY-107835S	Flumethrin-d5		/	Unkown
HY-110411	Chlorproethazine hydrochloride		/	Unkown
HY-111525	Monactin	Inhibitor	/	Unkown
HY-113486S1	lathosterol-d7		/	Unkown
HY-113778	15-keto-17-phenyl trinor Prostaglandin F2α		/	Unkown
HY-114986	6-Keto-PGE1	Inhibitor	99.0%	Unkown
HY-115371	Butaperazine dimaleate		/	Unkown
HY-116161	Bimatoprost isopropyl ester		/	Unkown
HY-116264	CatB-IN-1		/	Unkown
HY-116478	L-3373	Inhibitor	/	Unkown
HY-117284	Eucatropine	Inhibitor	/	Unkown
HY-117284A	Eucatropine hydrochloride	Inhibitor	/	Unkown
HY-117774	AHR-2244 hydrochloride		/	Unkown
HY-118092	JWU-A021	Activator	/	Unkown
HY-119512	Ethoxomane	Inhibitor	/	Unkown
HY-119925	Amaralin		/	Unkown
HY-120685	WAY-125971	Antagonist	/	Unkown
HY-121554	Kojic amine		/	Unkown
HY-121670	Ambenoxan		/	Unkown
HY-121670A	Ambenoxan hydrochloride		/	Unkown
HY-123449A	MK-761 TFA	Antagonist	99.93%	Unkown
HY-12392A	Iprindole hydrochloride	Agonist	/	Unkown
HY-124514	UC-857993	Inhibitor	/	Unkown
HY-124894	(+)-Benalaxyl	Inhibitor	/	Unkown
HY-126115	15(S)-Latanoprost	Inhibitor	/	Unkown
HY-126763	ATI22-107	Inhibitor	/	Unkown
HY-128383S	1-Methylpyrrolidine-d8		/	Unkown
HY-128383S1	1-Methylpyrrolidine-d3		/	Unkown
HY-129846	IBTP iodide		/	Unkown
HY-136894	Rhod-5N		/	Unkown
HY-137952	NS8593	Inhibitor	/	Unkown
HY-138058	AF-CX 921		/	Unkown
HY-14360	MK 1256	Inhibitor	/	Unkown
HY-143714	Cathepsin K inhibitor 2	Inhibitor	/	Unkown
HY-146580	Cathepsin C-IN-3	Inhibitor	/	Unkown
HY-146581	Cathepsin C-IN-4	Inhibitor	/	Unkown
HY-147186	5,5'-Difluoro BAPTA		/	Unkown
HY-147333	Trimipramine N-oxide		/	Unkown
HY-148156	Hydroxydione	Inhibitor	/	Unkown
HY-153614	Ac-VLPE-FMK	Inhibitor	99.0%	Unkown
HY-156045A	Cross-linked dextran G 10		/	Unkown
HY-157441	AChE/Aβ-IN-4	Inhibitor	/	Unkown
HY-157915	HFPB		/	Unkown
HY-165439	Indolidan	Inhibitor	/	Unkown
HY-165569	AU-1421	Modulator	/	Unkown
HY-171837A	t9,t11,c15-CLNA		/	Unkown
HY-172387	CM Cross-linked dextran C 25		/	Unkown
HY-172387A	CM Cross-linked dextran C 50		/	Unkown
HY-175498	RLA-3107	Inhibitor	/	Unkown
HY-178082	MK-251	Antagonist	/	Unkown
HY-178233	CAT335	Activator	/	Unkown
HY-178236	TRPM5 agonist-1	Inhibitor	/	Unkown
HY-179502	Anti-inflammatory agent 107		/	Unkown
HY-180384	1,10-Bis(methylsulfinyl)decane		/	Unkown
HY-180396	Ikarisoside B		/	Unkown
HY-180402	1,10-Bis(ethylsulfinyl)decane		/	Unkown
HY-181015	α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu		/	Unkown
HY-181174	Antioxidant agent-22		/	Unkown
HY-181430	PXS 25	Inhibitor	/	Unkown
HY-182296	SCH 79687	Antagonist	/	Unkown
HY-182363	A6CDQ		/	Unkown
HY-182469	FuBIG		/	Unkown
HY-182537	Org 9616 bromide		/	Unkown
HY-183268	TRPM4-IN-4	Inhibitor	/	Unkown
HY-184050	MERS-CoV-IN-3	Inhibitor	/	Unkown
HY-184140	AChE-IN-117	Inhibitor	/	Unkown
HY-184414	BMS-135-L-Lys		/	Unkown
HY-184414A	BMS-135-L-Lys TFA		/	Unkown
HY-184414B	BMS-135-L-Lys dihydrochloride		/	Unkown
HY-184530A	Flotufolastat Ga		/	Unkown
HY-184702	Aldose reductase-IN-10		/	Unkown
HY-A0157	Dimethothiazine	Antagonist	/	Unkown
HY-A0157A	Dimethothiazine mesylate	Antagonist	/	Unkown
HY-B0377G	Famotidine (GMP)		/	Unkown
HY-B0377S	Famotidine-13C,d3		/	Unkown
HY-B0565S	Ronidazole-d3	Inhibitor	/	Unkown
HY-B0932S1	Levocarnitine propionate-d5 hydrochloride		/	Unkown
HY-B1221S	Flufenamic acid-d4		/	Unkown
HY-D1640	5',5-Difluoro BAPTA tetrapotassium		/	Unkown
HY-D3207	DHUCu-1		/	Unkown
HY-D3212	Crisp-17		/	Unkown
HY-E70953	Pyruvate Kinase/Lactic Dehydrogenase enzymes, Rabbit		/	Unkown
HY-E70992	Eosinophil Peroxidase, Human		/	Unkown
HY-E71164	1,5-Anhydro-D-fructose dehydratase		/	Unkown
HY-E71636	3,4-Dihydroxy-2-butanone-4-phosphate synthase		/	Unkown
HY-N13756	Deoxymikanolide		/	Unkown
HY-N14351	Ferrocin A	Inhibitor	/	Unkown
HY-N17925	Falandioside B	Inhibitor	/	Unkown
HY-N19783	Carambolaside M		/	Unkown
HY-N20288	Spicate clerodendranthus extract		/	Unkown
HY-N20600	Ternate buttercup root extract		/	Unkown
HY-N6687A	Calcimycin hemicalcium salt		/	Unkown
HY-N6687B	Calcimycin hemimagnesium		/	Unkown
HY-N6687C	Calcimycin hemicalcium hemimagnesium		/	Unkown
HY-N7857	19(R)-Hydroxy-prostaglandin F2α		/	Unkown
HY-P10118	Cathepsin L-IN-3	Inhibitor	/	Unkown
HY-P10228	S-Thanatin	Inhibitor	/	Unkown
HY-P10652	hsBCL9CT-24	Inhibitor	/	Unkown
HY-P1471A	Adrenomedullin (AM) (22-52), human TFA	Antagonist	/	Unkown
HY-P1770A	Adrenomedullin (16-31), human TFA		/	Unkown
HY-P2324A	Gramicidin A TFA	Inhibitor	/	Unkown
HY-P3711	SPAI-1	Inhibitor	/	Unkown
HY-RS01982	CAT Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS05510	GLYAT Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W010736A	1,2-Dipalmitoyl-rac-glycerol		/	Unkown
HY-W011122	Tributylbenzylammonium bromide		98.0%	Unkown
HY-W013231	N-Benzyl-N,N-diethylethanaminium iodide		/	Unkown
HY-W013803	Xanthosine dihydrate	Activator	/	Unkown
HY-W075836	Ferrocenylmethyltrimethylammonium iodide		/	Unkown
HY-W087947	EDTA dihydrate tripotassium		97.0%	Unkown
HY-W699451	MTSET chloride	Inhibitor	/	Unkown
HY-W707517	Famotidine-d4		/	Unkown
HY-W711474	(-)-Menthol-d4		/	Unkown
HY-W724370	Tetraethylammonium bromide-d20		/	Unkown
HY-W748419	Acetylstrophanthidin		/	Unkown
HY-W753904S	Pradofloxacin-d4		/	Unkown
HY-W765177	Acetyl-L-carnitine hydrochloride-13C3		/	Unkown
HY-W773294	Tetramethylammonium silicate solution		/	Unkown
HY-W777002	Famotidine-13C3		/	Unkown
HY-W777365	Ethylenediaminetetraacetic acid-13C4		/	Unkown
HY-W783446A	DACH-Pt-SO4	Inhibitor	/	Unkown
HY-Y0682S2	Ethylenediaminetetraacetic acid-d4		/	Unkown
HY-101327AR	Xamoterol hemifumarate (Standard)	Agonist	/	Unkown
HY-101745	Rocastine	Inhibitor	/	Unkown
HY-106699	Taprostene sodium	Agonist	/	Unkown
HY-116889	15-Keto latanoprost acid		/	Unkown
HY-121285	Dioxadrol	Antagonist	/	Unkown
HY-122369	Histargin	Inhibitor	/	Unkown
HY-12392R	Iprindole (Standard)	Agonist	/	Unkown
HY-124492	Prindamine	Inhibitor	/	Unkown
HY-126605	Trinactin	Inhibitor	/	Unkown
HY-127147	Fazadinium bromide	Inhibitor	/	Unkown
HY-128383R	1-Methylpyrrolidine (Standard)		/	Unkown
HY-130325	α-Guanidinoglutaric acid	Inhibitor	98%	Unkown
HY-134268	8-Br-7-CH-ADPR	Antagonist	/	Unkown
HY-137639	Sp-8-Br-cGMPS	Agonist	/	Unkown
HY-139120	19(R)-hydroxy Prostaglandin E2		/	Unkown
HY-148034	Plm IV inhibitor-1	Inhibitor	/	Unkown
HY-157240	CEX Ion-exchange resin		/	Unkown
HY-157241	CEX Cation-exchange resin 1		/	Unkown
HY-157242	CEX Polishing resin		/	Unkown
HY-157243	CEX Cation-exchange resin 2		/	Unkown
HY-161612	Mycosporine 2 glycine	Inhibitor	/	Unkown
HY-163073	Anti-MRSA agent 9	Inhibitor	/	Unkown
HY-168363	Ciclotizolam	Ligand	/	Unkown
HY-170993	Antimicrobial agent-39	Inhibitor	/	Unkown
HY-175097	AL 8810 Ethyl amide		/	Unkown
HY-175862	ALR2-IN-9		/	Unkown
HY-182202	CAT Trimer phosphoramidite		/	Unkown
HY-182621	MB4253	Inhibitor	/	Unkown
HY-183176	Laurolinium acetate	Inhibitor	/	Unkown
HY-183840	PP185	Substrate	/	Unkown
HY-184084	Antiparasitic agent-45	Inhibitor	/	Unkown
HY-184085	Antiparasitic agent-46		/	Unkown
HY-184308	Antifungal agent-165		/	Unkown
HY-184374	Cyprolidol	Inhibitor	/	Unkown
HY-184756	Poly(1,4-phenylene sulfide)		/	Unkown
HY-186081	Ramiprilat acyl-β-D-glucuronide		/	Unkown
HY-23317	N-Methyl-4-(8-phenoxyoctoxy)aniline	Inhibitor	/	Unkown
HY-32350S1	Ercalcitriol-d3	Activator	/	Unkown
HY-B0377A	Famotidine hydrochloride		/	Unkown
HY-B0377S1	Famotidine-13C		/	Unkown
HY-B2035R	Pretilachlor (Standard)		/	Unkown
HY-N3989	Haplopine		99.49%	Unkown
HY-N7773	Hibiscetin		/	Unkown
HY-N8955	Maritimein		/	Unkown
HY-N9928	Echinenone	Inhibitor	/	Unkown
HY-RS16665	Cat Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS16943	Trpv6 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS19300	Mip Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS23100	Cat Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W008952	Tributyltetradecyl phosphonium chloride		/	Unkown
HY-W035412	4-((5-(4-Ethoxyphenoxy)pentyl)oxy)aniline	Inhibitor	/	Unkown
HY-W035445	Antiparasitic agent-42	Inhibitor	/	Unkown
HY-W108381	Pyriprole		/	Unkown
HY-W133968	Polyacrylate sodium		/	Unkown
HY-W291147	Pifexole		/	Unkown
HY-W654254	Malachite green-d5 oxalate		/	Unkown
HY-W658325	P-Decyloxyaniline		/	Unkown
HY-W715812	Bromuconazole		/	Unkown
HY-W747601	Chlorphoxim		/	Unkown
HY-W751579	Cefovecin	Inhibitor	/	Unkown
HY-W836666	5-LOX-IN-9	Inhibitor	/	Unkown

Inhibitory Antibodies (4)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99695	Lerdelimumab	Inhibitor	/	Unkown
HY-P990562	CAT-2200		/	Unkown
HY-P991906	TRPH-222 Antibody		/	Unkown
HY-P992011	CAT-07	Inhibitor	/	Unkown